Is There a Problem With Ezetimibe or Just ENHANCEd Hype?

Abstract

Get full access to this article

View all access options for this article.

References

Kastelein JJ , Akdim F. , Stroes ES , et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358:1431-1443.

Sager PT , Melani L. , Lipka L. , et al. Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein. Am J Cardiol. 2003;92:1414-1418.

Ridker PM Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein (hsCRP) in clinical practice. Am Heart Hosp J. 2004;2:4-9.

Berenson A. Cholesterol drug has no benefit in trial. The New York Times: Business. January14, 2008:1-2.

Winslow R. Cutting through the confusion over Vytorin. The Wall Street Journal. January 17, 2008:D-1, D-3.

American College of Cardiology. ACC Statement on ENHANCE Trial. http://www.acc.org/enhance.htm. Published January 15, 2008. Accessed June 16, 2008. 7. Sytkowski P, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med. 1990;322:1635-1641.

Whayne T. Evaluation and critique of state of the art dyslipidemia management in general and with a special emphasis on the Indian population. Indian Heart J. 2007;59:218-225.

Jones PH , Davidson MH , Stein EA , et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol. 2003;92:152-160.

Thompson P. , Clarkson, P. , Karas, RH Statin-associated myopathy. JAMA. 2003;289:1681-1690.

10.

Cannon CP , Braunwald E. , McCabe CH , et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 ;350:1495-1504.

11.

LaRosa JC , Grundy SM , Waters DD , et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425-1435.

12.

Mikhailidis DP , Sibbring GC , Ballantyne CM , et al. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin. 2007;23:2009-2026.

13.

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA. 1984;251:351-364.

14.

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984 ;251:365-374.